Toggle navigation
Home
About Us
Company Profile
Vision & Mission
Board Of Directors
R & D
Introduction
Dosage Form
Facility
Equipment
Products
NDDS
505 B(2)
Parenteral
Solid Oral Dosage Form
Ophthalmic
Peptide Synthesis
Services
Business Development
Contact Us
079 40359347
505 B(2)
Additional Strength
Dosage form change
IR to ER / DR
RTD
RTU
Note :
All anti cancer molucules can be formulate as RTU